Published in Proc Natl Acad Sci U S A on February 16, 2010
Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol (2010) 7.26
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nat Rev Cancer (2013) 3.08
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A (2010) 3.03
Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models. J Am Coll Surg (2012) 2.24
Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle (2011) 1.76
Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol (2011) 1.73
Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. Cancer Res (2012) 1.50
Integrin targeting for tumor optical imaging. Theranostics (2011) 1.47
Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice. J Surg Res (2013) 1.47
Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model. J Surg Res (2012) 1.47
Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time. Clin Cancer Res (2015) 1.41
Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. J Laparoendosc Adv Surg Tech A (2014) 1.40
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater (2011) 1.33
Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology (2012) 1.31
Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology. Theranostics (2014) 1.29
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med (2010) 1.28
Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer. Ann Surg Oncol (2014) 1.25
Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med (2010) 1.21
Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res (2013) 1.20
Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine (Lond) (2012) 1.17
Fluorescence imaging in surgery. IEEE Rev Biomed Eng (2013) 1.14
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer (2012) 1.11
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb) (2012) 1.11
M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett (2012) 1.11
Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc Natl Acad Sci U S A (2014) 1.10
Target-to-background enhancement in multispectral endoscopy with background autofluorescence mitigation for quantitative molecular imaging. J Biomed Opt (2014) 1.07
Submillimeter-resolution fluorescence laparoscopy of pancreatic cancer in a carcinomatosis mouse model visualizes metastases not seen with standard laparoscopy. J Laparoendosc Adv Surg Tech A (2011) 1.06
Framework for hyperspectral image processing and quantification for cancer detection during animal tumor surgery. J Biomed Opt (2015) 1.05
Molecular imaging for cancer diagnosis and surgery. Adv Drug Deliv Rev (2013) 1.04
Fluorescence-guided surgery and fluorescence laparoscopy for gastrointestinal cancers in clinically-relevant mouse models. Gastroenterol Res Pract (2013) 1.04
Detection limits of intraoperative near infrared imaging for tumor resection. J Surg Oncol (2010) 1.01
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes. Proc Natl Acad Sci U S A (2014) 0.99
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection. Theranostics (2013) 0.98
Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage. Int J Nanomedicine (2012) 0.97
Review of fluorescence guided surgery visualization and overlay techniques. Biomed Opt Express (2015) 0.97
Activatable molecular probes for cancer imaging. Curr Top Med Chem (2010) 0.97
Nanoparticles for multimodal in vivo imaging in nanomedicine. Int J Nanomedicine (2014) 0.96
In situ fluorescence imaging of myelination. J Histochem Cytochem (2010) 0.95
Intraoperative optical imaging and tissue interrogation during urologic surgery. Curr Opin Urol (2014) 0.95
Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery. Mol Cancer Ther (2014) 0.94
Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano (2013) 0.94
In vivo cancer imaging by poly(ethylene glycol)-b-poly(ɛ-caprolactone) micelles containing a near-infrared probe. Nanomedicine (2011) 0.94
Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev (2011) 0.93
Biological rationale for the design of polymeric anti-cancer nanomedicines. J Drug Target (2012) 0.93
Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther (2013) 0.92
A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see? Med Phys (2014) 0.92
Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. Cancer Res (2014) 0.91
Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.91
Stimulus-responsive nanopreparations for tumor targeting. Integr Biol (Camb) (2013) 0.91
Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation. PLoS One (2013) 0.91
Mitigating fluorescence spectral overlap in wide-field endoscopic imaging. J Biomed Opt (2013) 0.90
Fluorescent imaging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev (2014) 0.90
Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci (2013) 0.90
Microscopic Delineation of Medulloblastoma Margins in a Transgenic Mouse Model Using a Topically Applied VEGFR-1 Probe. Transl Oncol (2012) 0.89
Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu. Int J Cancer (2012) 0.89
Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance. Mol Pharm (2014) 0.89
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. Nat Commun (2012) 0.89
Fluorescence imaging agents in cancerology. Radiol Oncol (2010) 0.87
Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions. Bioconjug Chem (2011) 0.87
Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt (2016) 0.87
Early detection of thrombin activity in neuroinflammatory disease. Ann Neurol (2014) 0.87
Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors. Adv Mater (2015) 0.86
An integrated widefield imaging and spectroscopy system for contrast-enhanced, image-guided resection of tumors. IEEE Trans Biomed Eng (2015) 0.86
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg (2014) 0.85
Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Control Release (2015) 0.85
Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake. Nano Lett (2014) 0.84
Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model. PLoS One (2013) 0.84
Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol (2011) 0.84
Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes. Int J Surg Oncol (2012) 0.84
Preclinical molecular imaging of tumor angiogenesis. Q J Nucl Med Mol Imaging (2010) 0.83
Synthesis and photophysical properties of thioglycosylated chlorins, isobacteriochlorins, and bacteriochlorins for bioimaging and diagnostics. Bioconjug Chem (2010) 0.83
Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1. J Am Chem Soc (2012) 0.83
Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes. Sci Rep (2015) 0.82
Specific visualization of glioma cells in living low-grade tumor tissue. PLoS One (2010) 0.82
Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. Bioconjug Chem (2012) 0.82
In vivo imaging of mouse tumors by a lipidated cathepsin S substrate. Angew Chem Int Ed Engl (2014) 0.82
Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy. J Med Chem (2012) 0.81
Molecular imaging with surface-enhanced Raman spectroscopy nanoparticle reporters. MRS Bull (2013) 0.81
Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models. Ann Surg Oncol (2014) 0.81
Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers. Head Neck (2015) 0.81
Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges. Biomed Res Int (2015) 0.80
Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives. Expert Opin Med Diagn (2011) 0.80
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors. Nano Today (2013) 0.80
Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe. PLoS One (2014) 0.80
Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. Curr Pharm Biotechnol (2013) 0.80
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
In vivo mouse fluorescence imaging for folate-targeted delivery and release kinetics. Biomed Opt Express (2014) 0.80
Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery. ACS Chem Biol (2015) 0.79
Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden. Oncotarget (2015) 0.79
Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis. Tetrahedron (2013) 0.78
How can grafted breast cancer models be optimized? Cancer Biol Ther (2011) 0.78
Anion Recognition as a Supramolecular Switch of Cell Internalization. J Am Chem Soc (2016) 0.77
Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Br J Neurosurg (2015) 0.77
The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry. Sci Rep (2014) 0.77
Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore. J Am Chem Soc (2014) 0.77
Image-derived arterial input function for quantitative fluorescence imaging of receptor-drug binding in vivo. J Biophotonics (2015) 0.77
Stereoscopic Integrated Imaging Goggles for Multimodal Intraoperative Image Guidance. PLoS One (2015) 0.77
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A (2004) 4.95
Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23
New technologies for human cancer imaging. J Clin Oncol (2008) 3.46
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg (2002) 3.43
What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol (2008) 3.21
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A (2010) 3.03
Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg (2008) 2.41
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) (2009) 2.30
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer (2003) 2.29
Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation. World J Surg (2008) 2.27
Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology (2001) 2.24
A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res (2002) 1.97
Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol (1998) 1.88
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol (2007) 1.84
Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. Integr Biol (Camb) (2009) 1.78
ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci (2007) 1.54
Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology (2002) 1.34
Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer. Cancer Sci (2009) 1.29
Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg (2008) 1.28
Surgical margins and survival after head and neck cancer surgery. BMC Ear Nose Throat Disord (2006) 1.25
In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer (2007) 1.17
Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery (2009) 1.17
Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg (1998) 1.02
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
A monomeric red fluorescent protein. Proc Natl Acad Sci U S A (2002) 21.56
International network of cancer genome projects. Nature (2010) 20.35
Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science (2002) 18.89
A guide to choosing fluorescent proteins. Nat Methods (2005) 18.55
The fluorescent toolbox for assessing protein location and function. Science (2006) 14.02
Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24
Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol (2002) 9.25
Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Methods (2008) 8.41
New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc (2002) 5.83
Multicolor and electron microscopic imaging of connexin trafficking. Science (2002) 5.60
Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet (2010) 5.44
JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab (2007) 5.38
Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem (2004) 5.26
Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A (2004) 4.95
Characterization of engineered channelrhodopsin variants with improved properties and kinetics. Biophys J (2009) 4.75
Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem (2004) 4.75
Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science (2009) 4.67
Novel chromophores and buried charges control color in mFruits. Biochemistry (2006) 4.64
Visualizing the mechanical activation of Src. Nature (2005) 4.63
Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem Biol (2006) 4.52
Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci U S A (2004) 4.46
A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol (2003) 4.38
Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci U S A (2004) 4.37
A genetically encoded tag for correlated light and electron microscopy of intact cells, tissues, and organisms. PLoS Biol (2011) 4.07
Measuring calcium signaling using genetically targetable fluorescent indicators. Nat Protoc (2006) 3.96
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat Neurosci (2004) 3.64
Improving FRET dynamic range with bright green and red fluorescent proteins. Nat Methods (2012) 3.54
Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell (2009) 3.50
Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. Am J Hum Genet (2011) 3.43
Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. Nat Biotechnol (2005) 3.28
Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res (2004) 3.16
A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods (2005) 3.11
Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chem Biol (2009) 3.11
Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nat Rev Cancer (2013) 3.08
Development of a novel mouse glioma model using lentiviral vectors. Nat Med (2009) 3.08
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A (2010) 3.03
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci (2013) 2.98
A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol (2010) 2.93
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. Cancer Cell (2011) 2.70
Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68
Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. Nature (2005) 2.54
Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell (2008) 2.54
Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology (2010) 2.51
Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator. Nat Chem Biol (2007) 2.47
Single-spike detection in vitro and in vivo with a genetic Ca2+ sensor. Nat Methods (2008) 2.44
Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires. Proc Natl Acad Sci U S A (2012) 2.35
All-optical histology using ultrashort laser pulses. Neuron (2003) 2.33
BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell (2004) 2.32
Efficient and robust feature extraction by maximum margin criterion. IEEE Trans Neural Netw (2006) 2.32
Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem (2005) 2.31
Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene (2006) 2.31
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) (2009) 2.30
Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell (2011) 2.26
Exploration of new chromophore structures leads to the identification of improved blue fluorescent proteins. Biochemistry (2007) 2.23
Cortical depth-specific microvascular dilation underlies laminar differences in blood oxygenation level-dependent functional MRI signal. Proc Natl Acad Sci U S A (2010) 2.22
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A (2011) 2.22
Functional fluorescent Ca2+ indicator proteins in transgenic mice under TET control. PLoS Biol (2004) 2.20
Optogenetic inhibition of synaptic release with chromophore-assisted light inactivation (CALI). Neuron (2013) 2.16
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol (2011) 2.15
MSOAR: a high-throughput ortholog assignment system based on genome rearrangement. J Comput Biol (2007) 2.14
The Mg-chelatase H subunit of Arabidopsis antagonizes a group of WRKY transcription repressors to relieve ABA-responsive genes of inhibition. Plant Cell (2010) 2.13
Aptamers switch on fluorescence of triphenylmethane dyes. J Am Chem Soc (2003) 2.05
Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem (2004) 1.96
Genomic segmental polymorphisms in inbred mouse strains. Nat Genet (2004) 1.93
Estimation of allele frequency and association mapping using next-generation sequencing data. BMC Bioinformatics (2011) 1.93
Bone marrow-specific Cap gene deletion protects against high-fat diet-induced insulin resistance. Nat Med (2007) 1.91
Genetically targeted chromophore-assisted light inactivation. Nat Biotechnol (2003) 1.90
Efficient inference of haplotypes from genotypes on a pedigree. J Bioinform Comput Biol (2003) 1.89
Photoswitching mechanism of cyanine dyes. J Am Chem Soc (2009) 1.86
A new form of cerebellar long-term potentiation is postsynaptic and depends on nitric oxide but not cAMP. Proc Natl Acad Sci U S A (2002) 1.85
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett (2013) 1.82
Optical measurement of synaptic glutamate spillover and reuptake by linker optimized glutamate-sensitive fluorescent reporters. Proc Natl Acad Sci U S A (2008) 1.80
Computing the minimum recombinant haplotype configuration from incomplete genotype data on a pedigree by integer linear programming. J Comput Biol (2005) 1.78
Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. Integr Biol (Camb) (2009) 1.78
Golgi twins in late mitosis revealed by genetically encoded tags for live cell imaging and correlated electron microscopy. Proc Natl Acad Sci U S A (2006) 1.78
IsoLasso: a LASSO regression approach to RNA-Seq based transcriptome assembly. J Comput Biol (2011) 1.76
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer (2010) 1.74
Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol (2011) 1.73
Photo-inducible cell ablation in Caenorhabditis elegans using the genetically encoded singlet oxygen generating protein miniSOG. Proc Natl Acad Sci U S A (2012) 1.72
Inference of isoforms from short sequence reads. J Comput Biol (2011) 1.72
Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes (2005) 1.70
Imaging of cAMP levels and protein kinase A activity reveals that retinal waves drive oscillations in second-messenger cascades. J Neurosci (2006) 1.67